Corneal topography affected by external factors

Article

External factors can make data acquisition difficult during corneal topography examinations, according to a study published in the March issue of Eye &Contact Lens.

External factors can make data acquisition difficult during corneal topography examinations, according to a study published in the March issue of Eye & Contact Lens.

The study, led by Jose Manuel Gonzalez-Meijome, MD set out to analyse the factors affecting data acquisition during corneal topography examination with the Medmont E-300 videokeratoscope and to provide strategies to minimize their effects.

Sixty eyes from 30 young adults were examined, whilst a second observer recorded incidences that had the potential to affect data acquisition. These factors were correlated with difficulty of measurements as judged by the practitioner who performed the examination. Measurements of axial curvature were also analysed to evaluate the variability expressed as intrasession and intersession coefficient of variation and the standard error of the mean (SEM).

The results of the study indicated that the level of difficulty was generally low, with 70% of eyes being easy or very easy to measure. Corneal topography measurements were difficult in 27% of the remaining eyes or very difficult (3%). Only fixation instability (p<0.001) and the need for head repositioning (p=0.024) were associated with a higher level of difficulty. External factors were also shown to affect the variability of measurements at certain corneal locations, particularly in the vertical meridian when related to tear instability and in the horizontal meridian when related to repositioning on the chin rest owing to physiognomy interferences with the keratoscope cone.

The study concluded that the level of subjective difficulty found during videokeratoscopy examination is correlated strongly with fixation instability.

Recent Videos
Thomas Aaberg, MD, gives an update on Neurotech Pharmaceuticals NT-501 device for the potential treatment of retinitis pigmentosa and age-related macular degeneration, including a projected PDUFA date from the FDA at the annual ASRS meeting in Stockholm, Sweden.
Sruthi Arepalli, MD, spoke with Modern Retina about her presentation, "Assessing retinal vascular changes in alzheimer disease with radiomics: A preliminary study of fundus photography" at the annual ASRS meeting in Stockholm, Sweden.
Nathan Steinle, MD, spoke with Modern Retina about the ongoing research on the durability of sozinibercept in combination therapy with anti-VEGF-A treatments at the annual ASRS meeting in Stockholm, Sweden.
Deepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.